CareDx (CDNA) Restructuring Costs (2023 - 2024)
CareDx's (CDNA) quarterly Restructuring Costs came in at $1.7 million in Q4 2024, up 16.51% year-over-year from $1.5 million in Q1 2024, and up 2422.06% quarter-over-quarter from $68000.0 in Q2 2024.
Powered by 
Analysis
CareDx (CDNA) Restructuring Costs (2023 - 2024) Analysis & Trends
CareDx has disclosed Restructuring Costs across 2 years of filings, most recently posting $1.7 million for Q4 2024.
- In Q4 2024, Restructuring Costs rose 16.51% year-over-year to $1.7 million; the TTM figure through Dec 2024 stood at $3.3 million (up 40.3% YoY), while the FY2024 annual figure was $1.8 million, down 23.15% from the prior year.
- Restructuring Costs came in at $1.7 million for Q4 2024 at CareDx, up from $68000.0 in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $1.7 million in Q4 2024 to a low of $68000.0 in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn |
| 10 | CareDx | 2.77 Bn | 2.40 Bn | 116.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 1.72 Mn |
| Jun 30, 2024 | 68,000.00 |
| Dec 31, 2023 | 1.47 Mn |
| Jun 30, 2023 | 848,000.00 |